Duke's Hernandez Appointed to Reagan-Udall Foundation Board of Directors

The Reagan-Udall Foundation for the Food and Drug Administration has named Dr. Adrian F. Hernandez to its Board of Directors.

Dr. Hernandez brings extensive clinical and research experience to the Foundation’s leadership, having served as the Principal Investigator (PI) for several global clinical registries and trials. He is a recognized expert in clinical trial design, use of electronic health data, health services, and regulatory science.

 


About the Reagan-Udall Foundation for the FDA

The Reagan-Udall Foundation for the FDA (the Foundation) is an independent 501(c)(3) created by Congress to advance the mission of the FDA to modernize product development, accelerate innovation, and enhance product safety. The Foundation works to advance regulatory science, support development and dissemination of reliable information, and facilitate engagement and information exchange.

Media Contacts:

Lea Ann Browning-McNee
301-509-1846 (cell)
Lmcnee@reaganudall.org